Serological evidence of infection by rubella virus may be obtained by neutralization , complementfixation (Sever et at., 1965) , or haemagglutination-inhibition tests (Steward et al., 1967) . As rubella often presents atypically or even inapparently, diagnosis on clinical grounds alone is liable to error. Because of the risk of subsequent congenital malformations (Gregg, 1941) , serological tests are particularly valuable in the assessment of mothers exposed to or acquiring rubella early in pregnancy. Both neutralizing and haemagglutination-inhibiting (H.I.) antibodies often rise sharply to a high level early in the disease, a significant level of H.I. antibody sometimes being present on the first day of rash (Stewart et al., 1967; A. Field, personal communication) . In our experience many patients with rubella, particularly those who are pregnant, may be five to seven days or more from the onset of symptoms by the time they are referred for investigation. In these circumstances there may not be a significant rise in antibody titre between an acute phase sample of serum and a subsequent one taken two to three weeks later, both having equally elevated titres. This makes it impossible to say whether their antibody results from recent or from past infection. Although a rising or high complement-fixing antibody titre is useful, since it suggests relatively recent infection (Sever et at., 1965; Schmidt and Lennette, 1966) , a significant rise in antibody titre may not become detectable until four to six weeks after onset of symptoms (Sever et al., 1966 ; Banatvala, unpublished observations), peak titres sometimes being achieved as late as three to six months after infection (Veronelli and Eckert, 1966) .
The first immunoglobulins (IgM) to be detected after primary antigenic stimulus are of high molecular weight (Smith, 1960; Uhr and Finkelstein, 1963 ; Svehag and Mandel, 1964) . These are almost entirely replaced within a few weeks by those of lower molecular weight (IgG and IgA). This paper describes a method of detecting the presence of recently acquired rubella antibody by H.I. tests, titrating early and late convalescent sera in parallel before and after treatment with 2-mercaptoethanol (2ME); this being a sulphydryl-reducing compound which breaks down IgM immunoglobulins.
MATERIALS AND METHODS
Serial serum samples were obtained from patients with rubella at variable intervals from the day of onset (day 1), to 14 months after illness. Sera showing elevated H.I. titres in acute (day 1-5), early convalescent (day 7-30), or late convalescent (6 weeks to 14 months) were pretreated with 25 % kaolin and 50% day-old chick red blood cells according to the method described by Stewart et at., 1967. Sulphydryl reduction was demonstrated by treating sera with 1/10 volume 0.5 M 2ME for one hour at 370 C. An equal volume of phosphate-buffered saline was added to untreated sera. Antibody titres were measured by H.I. tests (Stewart et al., 1967) (Table II) , although complementfixing antibody titres persisted or increased. Thus reductions in antibody titre after treatment with 2ME indicated that infec- 
DISCUSSION
These results are similar to those obtained by Schluederberg (1965) , who found consistent twofold to fourfold reductions in antibody titre after treatment with 2ME in serum obtained at 12-day to 21-day intervals after measles vaccination and natural infection with mumps virus, but no reduction in those obtained two months or more after infection. Lindquist et al. (1965) , employing neutralization tests, observed fourfold or greater reductions in rubella antibody titre in seven of nine infants aged 10 weeks or less with the rubella syndrome, suggesting that, in addition to maternal IgG immunoglobulins, infants were synthesizing their own antibody, consisting principally of IgM components either before birth or in the neonatal period. Although treatment with 2ME provides a considerably less precise estimate of the presence of IgM immunoglobulins than, for example, analyses of antibody components by means of sucrose density gradients or gel filtration on Sephadex, the technique is simpler and can be used more readily if many sera have to be tested routinely. Even though the action of 2ME may not be entirely selective in breaking down only IgM immunoglobulins, both this and Schluederberg's series (1965) demonstrate that reduction in antibody titre after virus infection in early but not late convalescent sera, even though sometimes of small magnitude, is consistent. Reductions in antibody titre after treatment with 2ME compared favourably with complement-fixing tests as an index of recent infection by rubella virus. However, treatment with 2ME may be especially useful in assessing the duration of antibody in single serum samples obtained in the early stages of illness, a period at which greatest reductions in antibody titres are to be expected, or in obtaining evidence of recent infection in a proportion of patients who might present in early convalescence before complementfixing antibody has fully developed. These preliminary results suggest that this test, since it can be both simply and rapidly performed, may, in conjunction with virus isolation and other serological tests, be of additional value in the assessment of patients who have been contacts of or who gave a history of rubella during pregnancy. SUMMARY Eighteen of 21 (85.7%) acute and early convalescent sera from patients with rubella showed reduction in haemagglutination-inhibiting antibody titre after treatment with 2ME, whereas all late convalescent sera showed no reduction. This test provided a method for recognizing recent infection by rubella virus that may be particularly useful in the serological assessment of mothers contracting rubella during pregnancy. Large doses of corticosteroid (60 mg. of prednisolone daily) brought slow but steady improvement. He was able to walk, and fine movements of his hands were possible. Electromyographic changes, still
